secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001493152-25-027196
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric shareholders approve 50x increase in authorized shares and reverse split authority
--------------------------------------------------------------------------------

- Approved increase in authorized common shares from 100M to 5B (50x) at board discretion.
- Authorized reverse stock split at ratio between 1:5 and 1:15, with board to set exact ratio.
- Issuance proposal to issue shares underlying warrants for Nasdaq Rule 5635 compliance passed.
- Adjournment proposal rendered moot as quorum was achieved; all three proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315225027196/0001493152-25-027196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315225027196/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer